"Abnormal" cells such as vaccinia virus infected cells (1) and many tumor cells (2, 3) , appear to express additional (as compared with normal cells of that strain or individual) antigens that are cross-reactive with alloantigens detected serologicaily on normal cells of other strains or individuals. Tumor cells may also express antigens cross-reacive with target antigens of foreign haplotypes against which cell-mediated immune responses can be generated (2, (4) (5) (6) .
In vitro sensitization of responding human lymphocytes with a pool of allogeneic normal cells from 20 individuals results in the generation of cytotoxic T lymphocytes that lyse target cells from individuals that differ from the responding individual with regards to determinants recognized by cytotoxic lymphocytes, i.e. CD antigens I (7) . Included in such an ailogeneic pool of lymphocytes may be essentially all the CD-like antigens of the species. Whether sensitization with the pool may be an effective means to generate cytotoxic cells directed against syngeneic or autelogous abnormal target cells could be tested by using human lymphoblastoid cell lines (LCL) derived from lymphocytes transformed by Epstein-Barr virns (EBV) since LCL cells express target antigens recognized by lymphocytes sensitized against autologous LCL cells (8, 9).
The results reported herein demonstrate that sensitization of lymphocytes with the pool of allogeneic normal cells gives rise to effector cells cytotoxic to autologous LCL cells but not to autologous normal lymphocytes nor phytohemagglutinin (PHA) induced blasts. In contrast, sensitization of lymphocytes with cells from single allogeneic individuals rarely leads to the generation of effector cells cytotoxic for autologons LCL cells.
Materials and Methods
Lymphocytes were isolated from heparinized peripheral blood from normal healthy adults by Ficoll-Hypaque sedimentation. For some experiments, lymphocytes were fractionated into T-cellenriched and B-cell-enriched populations by rosetting with sheep erythrocytes (SRBC), centrifuging on a Ficell-Hypaque gradient, and isolating the cells at the interface (depleted of T cells) and * Lymphocytes from individuals A, S, and C were stimulated with X-irradiated autologous LCL cells (designated A-LCL, S-LCL, or C-LCL) or a pool of 20 allogeneic stimulating cells and lysis of the LCL cells and normal lymphocytes (A, S, and C) was measured on day 7. Lymphocytes from A, S, and C cultured in media alone caused -3.0-2.3% ~Cr release from autologous LCL cells.
the pellet containing rosetted cells (more than 95% T cells). The micromethod used for generating and assaying allogeneically induced cytotoxic human lymphocyte responses in vitro has been recently described (10) . In brief, 1 x 10 s responding lymphocytes/well were cultured with 1 x 105 X-irradiated (2,500 rads) stimulating cells from single unrelated individuals, with "pool" stimulating cells prepared by pooling equal numbers of lymphocytes from 5-20 unrelated individuals (7, 11) , or with 2 x 104 X-irradiated (4000 fads) autologous LCL cells. LCL cells were generated by infecting peripheral blood lymphocytes with EBV (12) and were grown in RPMI-1640 containing 25 mM Hepes buffer and 10% heat inactivated normal human serum; the LCL cells were used for experiments within 6 mo after their establishment and were found to be free of mycoplasma contamination. In some experiments, effector cells were generated in upright 50 ml tissue culture flasks as previously described (13) by using 8 x 10 e responding lymphocytes and 8 x 10 e Xirradiated pooled ailogeneic stimulating cells or 1.5 x 106 X-irradiated autologous LCL cells. 5~Cr release assays were performed 7 days after the onset of mixed culture and were terminated after 7 h. The percent specific 5'Cr release was calculated as previously described (10) . All sensitizations and cytotoxic assays were performed in medium consisting of RPMI-1640 containing 25 mM Hepes Buffer and 20% heat-inactivated normal human serum. Table I Table III In a second experiment, shown in Table III , sensitization of cells of individual S to a pool of either 8 or 18 members resulted in significant cytotoxicity for his autologous LCL cells as well as target cells from all 6 members of the pool tested. In contrast, effector cells generated in each of the eight individual mixed cultures did not lyse autologous LCL cells in any of the eight cases although § Lymphocytes were sensitized with X-irradiated normal lymphocytes from individuals designated A-H, with pooled cells from 8 of 18 individuals, or with autologous LCL cells and cytotoxicity on the allogeneic target cells derived from members of the pool and autologous LCL cells were assayed on day 7 by using a ratio of 25 effector cells:target cell. II SD ranged from 1.1 to 6.2% 51Cr release.
Results

Shown in
these same effector cells were highly cytotoxic for target cells derived from the sensitizing cell donors.
Since sensitization of lymphocytes from S with cells from individual 2 (Table  III) resulted in the generation of cytotoxic cells directed against autologous LCL cells, cold target inhibition studies were performed to determine whether lysis of LCL cells after pool sensitization was due solely to the presence of cells from individual 2 in the pool. When cells of S were sensitized to the pool and then tested for their ability to lyse slCr-labeled autologous LCL cells, the addition of unlabeled LCL cells blocked lysis whereas unlabeled target cells from individual 2 did not (Fig. 1A) . In contrast, when lymphocytes from S were sensitized with cells from individual 2, lysis of the autologous LCL cells was blocked equally well with unlabeled target cells from individual 2 or unlabeled LCL cells (Fig.  1B) . Lysis of target cells from individual 2 by lymphocytes sensitized to the pool or to cells of 2 was not blocked by the LCL cells but was by unlabeled target cells from individual 2. 1A ). We would interpret these findings to indicate that target antigens on the autologous LCL cells include determinants in addition to those shared by individual 2, and that the shared determinants represent a minority of all those that can be recognized by S's lymphocytes after pool sensitization.
It would seem that there are at least three mechanisms by which antigens expressed on LCL cells might cress-react with alloantigens. First, as a result of EBV infection or morphological transformation there may be derepression of genes coding for antigens that are expressed on normal cells of other members of the species (14, 15) . Second, EBV may code for cell membrane determinants that partially cross-react with many alloantigens. Third, any genetic or phenotypic modification of CD antigens might result in expression of target antigens that would be cross-reactive with alloantigens (16). Use of the pool may have general applicability in terms of generating effector cells cytotoxic for autologous or syngeneic virus infected or morphologically transformed cells (16).
Summary
Lymphocytes sensitized in vitro to a pool of X-irradiated allogeneic normal lymphocytes from 20 individuals develop cytotoxic activity for autologous human lymphoblastoid cells (LCL). Whereas pool sensitized T lymphocytes lyse autologous LCL cells, they fail to lyse autologous B-enriched or T-enriched normal target cells nor autologous phytohemagglutinin (PHA) blasts. In contrast to pool sensitization, stimulation with normal cells of single allogeneic individuals rarely led to development of cytotoxicity against autologous LCL cells. We conclude that human Epstein-Barr virus transformed LCL cells express target antigens cross-reactive with allogeneic target antigens expressed on normal cells and that sensitization with a pool of allogeneic cells is an effective means of generating effector cells directed against autologous abnormal cells.
